Co-Diagnostics, Inc. (CODX) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Co-diagnostics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.655 Thank you for standing by. At this time, I would like to welcome everyone to the Co-Diagnostics, 00:00:05.655 -- 00:00:10.359 Inc., second quarter 2026 earnings webcast. 00:00:10.359 -- 00:00:14.822 All lines have been placed on mute to prevent any background noise. 00:00:14.822 -- 00:00:19.065 After the speaker's remarks, there will be a question and answer session. 00:00:19.065 -- 00:00:23.388 If you would like to ask a question during this time, simply press star followed by the 00:00:23.388 -- 00:00:28.685 number one on your telephone keypad. I would now like to turn the conference over to 00:00:28.685 -- 00:00:31.366 Andrew Benson, Head of Investor Relations. 00:00:31.366 -- 00:00:33.926 The floor is yours. 00:00:33.926 -- 00:00:37.928 Good afternoon, everyone. Thank you all for participating in today's conference call. 00:00:37.928 -- 00:00:42.829 On the line today from CoDiagnostics, we have Dwight Egan, Chief Executive Officer, and 00:00:42.829 -- 00:00:47.911 Brian Brown, Chief Financial Officer. Earlier today, CoDiagnostics released financial 00:00:47.911 -- 00:00:52.012 results from the second quarter ended June 30, 2026. 00:00:52.012 -- 00:00:55.337 A copy of the press release is available on the company's website. 00:00:55.337 -- 00:00:59.720 We will begin with management's prepared remarks and then open up the call to analyst 00:00:59.720 -- 00:01:04.543 Q&A. Before we begin, we would like to inform listeners that certain statements made 00:01:04.543 -- 00:01:09.105 by co-diagnostics during this call, which are not historical facts, are forward-looking 00:01:09.105 -- 00:01:14.068 statements. In addition to diagnostic test developments and clinical evaluation timelines, 00:01:14.068 -- 00:01:18.471 this includes state...